Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024
SAN FRANCISCO and SUZHOU, China, Nov. 24, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabol
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection
SHANGHAI, Nov. 25, 2024 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial vir
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its Phase 1 trial of SCG101, a first-in-class autolo
Hurom H400 Named Best Kitchen Product of 2024 by Forbes
Mega Hopper Maximizes Convenience with Easy Assembly and Cleaning High-Quality, Pulp-Free Juicing Performance Praised SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ — Hurom’s flagship H400 juicer has been awarded Best Kitchen Product of the Year by Forbes as part of the 2024 Forbes Vette
Media Advisory – Deputy Prime Minister’s itinerary for Monday, November 25, 2024
OTTAWA, ON, Nov. 24, 2024 /CNW/ – Note: All times local. Ottawa, Ontario Private meetings. 1:00 p.m. The Deputy Prime Minister will provide an update on the government’s economic plan. She will be joined by the Minister of Public Services and Procurement and Quebec Lieutenant, Jean-Yve
XRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Xerox Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Nov. 24, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Xerox Holdings Corporation (“Xerox” or “the Company”) (NAS
Jet-Set for Less with Trip.com’s Black Friday Mega Sale
SYDNEY, Nov. 25, 2024 /PRNewswire/ — Trip.com is thrilled to announce the launch of its highly anticipated Black Friday Mega Sale, offering an array of incredible travel deals and exclusive promotions. Get ready to pack your bags and jet off to your dream destination! From 18 November to 8 Dec
Hyundai Capital Services Marks Another Major Milestone, Launches Hyundai Finance in Australia
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ — Hyundai Capital Services (“Hyundai Capital” or the “Company”), the financial subsidiary of the Hyundai Motor Group, announced today launch of its finance options for Hyundai Motor Company in Australia. This launch marks a
V INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Visa Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Nov. 24, 2024 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Visa Inc. (“Visa” or “the Company”) (NYSE: V) and certain
Introducing Allianz Travel Insurance, formerly Worldcare
Now bringing Kiwis customisable coverage under the no. 1 insurance brand worldwide AUCKLAND, New Zealand, Nov. 25, 2024 /PRNewswire/ — Allianz Partners (AWP Services New Zealand Ltd) is announcing that Worldcare has changed its name to Allianz Travel Insurance — now offering New Zealand cust
